7 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Methyl-Transferase-Like Protein 16 (METTL16): The Intriguing Journey of a Key Epitranscriptomic Player Becoming an Emerging Biological Target.
University of Naples Federico II
Small molecules that regulate the N6-methyladenosine RNA modification as potential anti-cancer agents.
University of Connecticut
Rational design of novel nucleoside analogues reveals potent antiviral agents for EV71.
Swansea University
METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey.
Sapienza University of Rome
Roles and drug development of METTL3 (methyltransferase-like 3) in anti-tumor therapy.
Yunnan University
1,4,9-Triazaspiro[5.5]undecan-2-one Derivatives as Potent and Selective METTL3 Inhibitors.
University of Zurich